BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 9346547)

  • 1. CA19-9 does not predict cholangiocarcinoma in patients with primary sclerosing cholangitis undergoing liver transplantation.
    Fisher A; Theise ND; Min A; Mor E; Emre S; Pearl A; Schwartz ME; Miller CM; Sheiner PA
    Liver Transpl Surg; 1995 Mar; 1(2):94-8. PubMed ID: 9346547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FUT2 and FUT3 genotype determines CA19-9 cut-off values for detection of cholangiocarcinoma in patients with primary sclerosing cholangitis.
    Wannhoff A; Hov JR; Folseraas T; Rupp C; Friedrich K; Anmarkrud JA; Weiss KH; Sauer P; Schirmacher P; Boberg KM; Stremmel W; Karlsen TH; Gotthardt DN
    J Hepatol; 2013 Dec; 59(6):1278-84. PubMed ID: 23958938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biliary brush cytology and the detection of cholangiocarcinoma in primary sclerosing cholangitis: evaluation of specific cytomorphologic features and CA19-9 levels.
    Furmanczyk PS; Grieco VS; Agoff SN
    Am J Clin Pathol; 2005 Sep; 124(3):355-60. PubMed ID: 16191503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis.
    Siqueira E; Schoen RE; Silverman W; Martin J; Rabinovitz M; Weissfeld JL; Abu-Elmaagd K; Madariaga JR; Slivka A
    Gastrointest Endosc; 2002 Jul; 56(1):40-7. PubMed ID: 12085033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and management of cholangiocarcinoma in primary sclerosing cholangitis.
    Ahrendt SA; Pitt HA; Nakeeb A; Klein AS; Lillemoe KD; Kalloo AN; Cameron JL
    J Gastrointest Surg; 1999; 3(4):357-67; discussion 367-8. PubMed ID: 10482687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis.
    Charatcharoenwitthaya P; Enders FB; Halling KC; Lindor KD
    Hepatology; 2008 Oct; 48(4):1106-17. PubMed ID: 18785620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 3-year prospective study on serum tumor markers used for detecting cholangiocarcinoma in patients with primary sclerosing cholangitis.
    Hultcrantz R; Olsson R; Danielsson A; Järnerot G; Lööf L; Ryden BO; Wahren B; Broomé U
    J Hepatol; 1999 Apr; 30(4):669-73. PubMed ID: 10207809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of serum CA 19-9 in predicting cholangiocarcinomas in patients with primary sclerosing cholangitis.
    Levy C; Lymp J; Angulo P; Gores GJ; Larusso N; Lindor KD
    Dig Dis Sci; 2005 Sep; 50(9):1734-40. PubMed ID: 16133981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CA 19-9 and CEA are unreliable markers for cholangiocarcinoma in patients with primary sclerosing cholangitis.
    Björnsson E; Kilander A; Olsson R
    Liver; 1999 Dec; 19(6):501-8. PubMed ID: 10661684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristic Features of Cholangiocarcinoma Complicating Primary Sclerosing Cholangitis.
    Ishii Y; Sasaki T; Serikawa M; Kobayashi K; Kamigaki M; Minami T; Okazaki A; Yukutake M; Ishigaki T; Kosaka K; Mouri T; Yoshimi S; Chayama K
    Hepatogastroenterology; 2014 May; 61(131):567-73. PubMed ID: 26176037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective surveillance for cholangiocarcinoma in unselected individuals with primary sclerosing cholangitis.
    Villard C; Friis-Liby I; Rorsman F; Said K; Warnqvist A; Cornillet M; Kechagias S; Nyhlin N; Werner M; Janczewska I; Hagström T; Nilsson E; Bergquist A
    J Hepatol; 2023 Mar; 78(3):604-613. PubMed ID: 36410555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.
    Goss JA; Shackleton CR; Farmer DG; Arnaout WS; Seu P; Markowitz JS; Martin P; Stribling RJ; Goldstein LI; Busuttil RW
    Ann Surg; 1997 May; 225(5):472-81; discussion 481-3. PubMed ID: 9193175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor markers as a diagnostic key for hilar cholangiocarcinoma.
    Juntermanns B; Radunz S; Heuer M; Hertel S; Reis H; Neuhaus JP; Vernadakis S; Trarbach T; Paul A; Kaiser GM
    Eur J Med Res; 2010 Aug; 15(8):357-61. PubMed ID: 20947473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suspicious brush cytology is an indication for liver transplantation evaluation in primary sclerosing cholangitis.
    Boyd S; Vannas M; Jokelainen K; Isoniemi H; Mäkisalo H; Färkkilä MA; Arola J
    World J Gastroenterol; 2017 Sep; 23(33):6147-6154. PubMed ID: 28970730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Detection of Cholangiocarcinoma in Primary Sclerosing Cholangitis Patients: Single Center Experience.
    Kuzu UB; Ödemiş B; Suna N; Yıldız H; Parlak E; Dişibeyaz S; Torun S; Akpınar MY; Coşkun O; Turhan N; Yüksel M; Kayaçetin E
    J Gastrointest Cancer; 2016 Mar; 47(1):8-14. PubMed ID: 26537791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated perioperative serum CA 19-9 levels are independent predictors of poor survival in patients with resectable cholangiocarcinoma.
    Kondo N; Murakami Y; Uemura K; Sudo T; Hashimoto Y; Sasaki H; Sueda T
    J Surg Oncol; 2014 Sep; 110(4):422-9. PubMed ID: 24889968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis.
    Patel AH; Harnois DM; Klee GG; LaRusso NF; Gores GJ
    Am J Gastroenterol; 2000 Jan; 95(1):204-7. PubMed ID: 10638584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment for liver transplantation in patients with primary sclerosing cholangitis.
    Broomé U; Eriksson LS
    J Hepatol; 1994 May; 20(5):654-9. PubMed ID: 8071544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced detection of cholangiocarcinoma with serum trypsinogen-2 in patients with severe bile duct strictures.
    Lempinen M; Isoniemi H; Mäkisalo H; Nordin A; Halme L; Arola J; Höckerstedt K; Stenman UH
    J Hepatol; 2007 Nov; 47(5):677-83. PubMed ID: 17640760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined adult-to-adult living donor right lobe liver transplantation and pancreatoduodenectomy for distal bile duct adenocarcinoma in a patient with primary sclerosing cholangitis.
    Varotti G; Gondolesi GE; Roayaie S; Suriawinata A; Soltys K; Fishbein TM; Schwartz ME; Miller C
    J Am Coll Surg; 2003 Nov; 197(5):765-9. PubMed ID: 14585411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.